Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001359820-15-000004

CEO bought 25,000 shares at an average $1.27 ($31,737)

From the SEC's structured data for this filing

Trades in this filing

Babcock Dwight William · CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2015-11-12 Purchase : show line 1 in the form +200 $1.26 $251 301,602 D
2015-11-12 Purchase : show line 2 in the form +1,000 $1.26 $1,260 302,602 D
2015-11-12 Purchase : show line 3 in the form +23,800 $1.27 $30,226 326,402 D
Open-market purchases · 25,000 sh · avg $1.27 · $31,737
Loading xslF345X03/primary_doc.xml…